BridgeMD
New treatment option for Ventilator Associated Pneumonia (VAP)
Official title Effect of Implementing Evidence-based Practice and Nurse's Behavior Change on Quality of Care in Intensive Care Unit: Focus on Ventilator Associated Pneumonia in a Tertiary Hospital in Bangladesh
ClinicalTrials.gov ID: NCT06624540
What this study is testing
- What it's testing
- Quality of care is crucial for preventing adverse events such as infection in the intensive care units (ICUs). The most common ICU-acquired infections include pneumonia such as ventilator-associated pneumonia (VAP), Central Line Bloodstream Infection (CLABSI), catheter-associated urinary tract in, Medical Device Related Pressure Ulcer (MDRPU) and Pressure Ulcer (PU).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Study 2:
- Who will be a registered nurse in Bangladesh.
- Who will agree to participate in this study and the EBP training.
You likely can't join if
- Who will not directly involve patient care in ICU. Study 3: Inclusion Criteria:
- Irrespective of age and sex, participant must be 18 years old.
- Legal guardian of a patient consents to participation in the study
- Intubated patients after admission. Exclusion Criteria:
- Who stays less than 2 days at the GICU.
- Who dies or is extubated within 2 days after admitted in the GICU.
See the full eligibility criteria
- Study 2:
- Who will be a registered nurse in Bangladesh.
- Who will agree to participate in this study and the EBP training.
- Who will not directly involve patient care in ICU. Study 3: Inclusion Criteria:
- Irrespective of age and sex, participant must be 18 years old.
- Legal guardian of a patient consents to participation in the study
- Intubated patients after admission. Exclusion Criteria:
- Who stays less than 2 days at the GICU.
- Who dies or is extubated within 2 days after admitted in the GICU.
- ICU readmission.
The study team makes the final eligibility decision.
Where it's taking place
- Dhaka, Bangladesh
- Hiroshima, Kasumi 1-2-3 Minami-ku, Japan
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dhaka, Bangladesh; Hiroshima, Kasumi 1-2-3 Minami-ku, Japan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.